Merck & Co. Acquires Modifi Biosciences in Deal Worth Up to $1.3 Billion

On October 23, biotechnology company Modifi Biosciences announced that it had been acquired by Merck & Co., Inc., which is known as MSD outside the United States and Canada.MSDAccording to the terms of the agreement, MSD, through a subsidiary, acquired all outstanding shares of Modifi Biosciences for an upfront payment of $30 million. Shareholders of Modifi Biosciences are also eligible to receive potential milestone payments totaling up to $1.3 billion.

Editor: Li Tong